New patent for Gilead Sciences drug VEKLURY
Annual Drug Patent Expirations for VEKLURY Veklury is a drug marketed by Gilead Sciences Inc and is included in one […]
Patent Added
New patent for Pharmacyclics Llc drug IMBRUVICA
Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Llc and is included in three NDAs.
New patent for Ironshore Pharms drug JORNAY PM
Annual Drug Patent Expirations for JORNAY+PM Jornay Pm is a drug marketed by Ironshore Pharms and is included in one
New patent for Gilead Sciences drug BIKTARVY
Annual Drug Patent Expirations for BIKTARVY Biktarvy is a drug marketed by Gilead Sciences Inc and is included in one
New patent for Pacira Pharms drug EXPAREL
Annual Drug Patent Expirations for EXPAREL Exparel is a drug marketed by Pacira Pharms Inc and is included in one
New patent for United Therap drug TYVASO
Annual Drug Patent Expirations for TYVASO Tyvaso is a drug marketed by United Therap and is included in two NDAs.
New patent for United Therap drug TYVASO DPI
Annual Drug Patent Expirations for TYVASO+DPI Tyvaso Dpi is a drug marketed by United Therap and is included in one
New patent for Gilead Sciences drug VEKLURY
Annual Drug Patent Expirations for VEKLURY Veklury is a drug marketed by Gilead Sciences Inc and is included in one
New patent for Apellis Pharms drug SYFOVRE
Annual Drug Patent Expirations for SYFOVRE Syfovre is a drug marketed by Apellis Pharms and is included in one NDA.
